Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety

International Journal of Pharmaceutics
Harinder SinghIndu Pal Kaur

Abstract

Rifampicin (RIF) was encapsulated into solid lipid nanoparticles (SLNs) to overcome its poor and unreliable oral bioavailability. Novel microemulsification method with high drug loading (50%) and entrapment efficiency (∼67%) was developed (Indian Patent Application 3356/DEL/2013). RIF-SLNs were characterized using TEM, AFM, DSC and XRD. Near neutral SLNs (zeta -3.5 ± 0.8), with average particle size of 130.0 ± 22.6 nm showed 70.12% release in phosphate buffer pH 6.8 in 9 days. Single oral dose (50mg/kg) pharmacokinetic studies in Wistar rats indicated 8.14 times higher (in comparison to free RIF) plasma bioavailability with sustained levels for 5 days. Pharmacodynamic parameters viz. TMIC (120 h; time for which plasma levels were above MIC of 0.2 μg/ml), AUC0-∞/MIC (1868.9h) and Cmax/MIC (75.6) for RIF-SLNs were greater than free RIF by 2.5, 8.2 and 6.6 times, respectively. Similar LD50 (1570 mg/kg) and absence (or reversal in satellite group) of adverse events in repeat dose (three doses; highest dose was up to 50 times the human therapeutic dose) toxicity studies confirmed safety of RIF-SLNs. Improved pharmacokinetic profile of RIF-SLNs can be translated to a reduced dose and dosage frequency of RIF, thus resulting in lower o...Continue Reading

References

Mar 1, 1977·The Journal of Antimicrobial Chemotherapy·D J Girling
Mar 1, 1997·Clinics in Chest Medicine·C A Peloquin
Mar 1, 1991·Archives of Pharmacal Research·Y P YunJ H Chung
Sep 29, 2001·International Journal of Pharmaceutics·C J ShishooM J Vora
Oct 24, 2001·International Journal of Antimicrobial Agents·M Dutt, G K Khuller
Mar 26, 2003·The Journal of Antimicrobial Chemotherapy· Qurrat-ul-AinS K Garg
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Ramesh JayaramV Balasubramanian
Jul 15, 2003·Clinical Microbiology Reviews·Issar Smith
Nov 17, 2004·Current Pharmaceutical Design·G K KhullerSadhna Sharma
Nov 27, 2004·The Journal of Pharmacy and Pharmacology·LianDong HuFuDe Cui
Nov 1, 2005·Tuberculosis·Rajesh PandeyG K Khuller
Apr 4, 2006·International Journal of Pharmaceutics·R H MüllerE B Souto
Apr 4, 2006·Molecular and Cellular Biochemistry·Satya V RanaKartar Singh
Apr 7, 2006·The Journal of Antimicrobial Chemotherapy·Rajesh Pandey, G K Khuller
Jul 25, 2006·Tuberculosis·Sakarin ChanwongSanit Makonkawkeyoon
Jun 16, 2007·Advanced Drug Delivery Reviews·Paolo BlasiCarlo Rossi
Dec 20, 2008·Nanomedicine : Nanotechnology, Biology, and Medicine·Rishi PaliwalSuresh P Vyas
Oct 13, 2010·Molecular Nutrition & Food Research·Vandita KakkarIndu Pal Kaur
Nov 22, 2011·Particle and Fibre Toxicology·Shuyu XieWenzhong Zhou
Aug 28, 2012·International Journal of Nanomedicine·Ying-Chen ChenMing-Thau Sheu
Dec 12, 2012·International Journal of Pharmaceutics·Rohit Bhandari, Indu Pal Kaur
Apr 6, 2013·International Journal of Pharmaceutics·Vandita KakkarIndu Pal Kaur
Aug 9, 2013·International Journal of Nanomedicine·Arshad Ali KhanYusrida Darwis
Apr 16, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Indu Pal Kaur, Harinder Singh

❮ Previous
Next ❯

Citations

Sep 11, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Jiří TrousilPetr Štěpánek
May 5, 2016·Drug Development and Industrial Pharmacy·Rakesh Kumar, Vivek Ranjan Sinha
Apr 4, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Jalal GhaderkhaniRoghayeh Abbasalipourkabir
Aug 7, 2019·Current Drug Metabolism·Ayse Basak Engin, Atilla Engin
Sep 22, 2018·Pharmaceutical Research·Estefania GrotzMarcela A Moretton
Jan 27, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Mandeep SinghIndu Pal Kaur
Jan 28, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Rohit BhandariIndu Pal Kaur
Dec 10, 2020·International Journal of Nanomedicine·Ze-Liang WuRong Xu
Oct 30, 2020·International Journal of Nanomedicine·Qiuzhen LiangXinghua Song
Mar 24, 2021·Nature Nanotechnology·Ameya R KirtaneGiovanni Traverso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.